نتایج جستجو برای: 963

تعداد نتایج: 1023  

Journal: :Annual review of biochemistry 1990
S C Harrison A K Aggarwal

INTRODUCTION......... . ...... ................. .. ................. . .... . . ................. ......... 933 NOTIONS ABOUT RECOGNITION..... ................ . . .............. . . ..... . ......... . . ..... 934 THE HTH MOTIF... ..... ....... ................. .. . ................ .... . . .... ........... . .. . ..... .. 936 STRUCTURES.... . . . ..... .. ......... . . ................ ......

Journal: :The Journal of pharmacology and experimental therapeutics 2004
Richard R Harris Lawrence Black Sekhar Surapaneni Teodozyj Kolasa Sandra Majest Marian T Namovic George Grayson Victoria Komater Denise Wilcox Linda King Kennan Marsh Michael F Jarvis Merrill Nuss Hugh Nellans Lee Pruesser Glenn A Reinhart Bryan Cox Peer Jacobson Andrew Stewart Michael Coghlan George Carter Randy L Bell

Nonsteriodal anti-inflammatory drugs (NSAIDs) are efficacious for the treatment of pain associated with inflammatory disease. Clinical experience with marketed selective cyclooxygenase-2 (COX-2) inhibitors (celecoxib, rofecoxib, and valdecoxib) has confirmed the utility of these agents in the treatment of inflammatory pain with an improved gastrointestinal safety profile relative to NSAID compa...

Journal: :The British journal of ophthalmology 2010
H S Dua I Rahman A Miri D G Said

http://bjo.bmj.com/content/94/8/963.full.html Updated information and services can be found at: These include: References http://bjo.bmj.com/content/94/8/963.full.html#ref-list-1 This article cites 13 articles, 3 of which can be accessed free at: service Email alerting box at the top right corner of the online article. Receive free email alerts when new articles cite this article. Sign up in th...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2003
Hao Chen Weiqi Chen Liang-Shang Gan Abdul E Mutlib

(S)-5, 6-Difluoro-4-cyclopropylethynyl-4-trifluoromethyl-3, 4-dihydro- 2-(1H)-quinazolinone (DPC 963), a specific non-nucleoside inhibitor of human immunodeficiency virus-1 reverse transcriptase, is primarily metabolized in humans to the glucuronide conjugate of 8-OH DPC 963 (M8). Electrospray ionization-liquid chromatography/mass spectrometry analyses of urine from subjects dosed with DPC 963 ...

Journal: :Symmetry 2016
Sergio Castiñeira-Ibáñez Daniel Tarrazó-Serrano Constanza Rubio Pilar Candelas Antonio Uris

Sergio Castiñeira-Ibáñez 1, Daniel Tarrazó-Serrano 2, Constanza Rubio 2,*, Pilar Candelas 2 and Antonio Uris 2 1 Departamento de Ingeniería Electrónica, Universitat de València, Avd. de la Universitat s/n, Burjassot, Valencia 46100, Spain; [email protected] 2 Centro de Tecnologías Físicas, Universitat Politècnica de València, Camino de Vera s/n, Valencia 46022, Spain; [email protected] (D.T.-S.); ...

Journal: :The Journal of clinical investigation 2007
Steve H Thorne Tae-Ho H Hwang William E O'Gorman David L Bartlett Shizuko Sei Femina Kanji Christopher Brown Joel Werier Jin-Han Cho Dong-Ewon Lee Yaohe Wang John Bell David H Kirn

Replication-selective oncolytic viruses (virotherapeutics) are being developed as novel cancer therapies with unique mechanisms of action, but limitations in i.v. delivery to tumors and systemic efficacy have highlighted the need for improved agents for this therapeutic class to realize its potential. Here we describe the rational, stepwise design and evaluation of a systemically effective viro...

2016
Mohammad Asif

Vicinally disubstituted pyridazinones act as potent and selective COX-2 inhibitors. Compound, ABT-963, (2-(3,4-difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one) has an excellent selectivity (ratio of 276, COX-2/COX-1), improved aqueous solubility compared with celecoxib and rofecoxib, high oral anti-inflammatory potency and gastric safety in the ani...

Journal: :Clinical Infectious Diseases 1996

2012
EDWARD K. CHENG

INTRODUCTION ................................................................................ 955 I. AVERAGING ................................................................................ 958 II. SHRINKAGE ................................................................................ 960 III. NONRANDOM SAMPLING ............................................................. 963 CONCLUSION ....

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید